Albert Gris-Oliver

Vall dHebron Inst Oncol Expt Therapeut Grp, Barcelona, Spain

关注

立即认领

关注

立即认领

基本信息

浏览量：11

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 36 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Table S2 from MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García,Martín A. Rivas,Yasir H. Ibrahim,María Teresa Calvo,Albert Gris-Oliver,Olga Rodríguez,Judit Grueso,Pilar Antón,Marta Guzmán,Claudia Aura,Paolo Nuciforo,Katti Jessen,Guillem Argilés,Rodrigo Dienstmann,Andrea Bertotti,Livio Trusolino,Judit Matito,Ana Vivancos,Irene Chicote,Héctor G. Palmer,Josep Tabernero,Maurizio Scaltriti,José Baselga,Violeta Serra

crossref（2023）

引用0浏览0引用

Table S1 from Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

Albert Gris-Oliver,Marta Palafox,Laia Monserrat,Fara Brasó-Maristany,Andreu Òdena,Mònica Sánchez-Guixé,Yasir H. Ibrahim,Guillermo Villacampa,Judit Grueso,Mireia Parés,Marta Guzmán,Olga Rodríguez,Alejandra Bruna,Caroline S. Hirst,Alan Barnicle,Elza C. de Bruin,Avinash Reddy,Gaia Schiavon,Joaquín Arribas, Gordon B. Mills,Carlos Caldas,Rodrigo Dienstmann,Aleix Prat,Paolo Nuciforo,Pedram Razavi,Maurizio Scaltriti, Nicholas C. Turner,Cristina Saura, Barry R. Davies,Mafalda Oliveira,Violeta Serra

crossref（2023）

引用0浏览0引用

Table S4 from MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer

crossref（2023）

引用0浏览0引用

Table S3 from MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer

crossref（2023）

引用0浏览0引用

Table S2 from MEK Plus PI3K/mTORC1/2 Therapeutic Efficacy is Impacted by tp53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García,Martín A. Rivas,Yasir H. Ibrahim,María Teresa Calvo,Albert Gris-Oliver,Olga Rodríguez,Judit Grueso,Pilar Antón,Marta Guzmán,Claudia Aura,Paolo Nuciforo,Katti Jessen,Guillem Argilés,Rodrigo Dienstmann,Andrea Bertotti,Livio Trusolino,Judit Matito,Ana Vivancos,Irene Chicote,Héctor G. Pálmer,Josep Tabernero,Maurizio Scaltriti,José Baselga,Violeta Serra

openalex（2023）

引用0浏览0引用

Figure S1 from Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

Albert Gris-Oliver,Marta Palafox,Laia Monserrat,Fara Brasó-Maristany,Andreu Òdena,Mònica Sánchez-Guixé,Yasir H. Ibrahim,Guillermo Villacampa,Judit Grueso,Mireia Parés,Marta Guzmán,Olga Rodríguez,Alejandra Bruna,Caroline S. Hirst,Alan Barnicle,Elza C. de Bruin,Avinash Reddy,Gaia Schiavon,Joaquín Arribas,Gordon B. Mills,Carlos Caldas,Rodrigo Dienstmann,Aleix Prat,Paolo Nuciforo,Pedram Razavi,Maurizio Scaltriti, Nicholas C. Turner,Cristina Saura, Barry R. Davies,Mafalda Oliveira,Violeta Serra

openalex（2023）

引用0浏览0引用

Table S1 from MEK Plus PI3K/mTORC1/2 Therapeutic Efficacy is Impacted by tp53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García,Martín A. Rivas,Yasir H. Ibrahim,María Teresa Calvo,Albert Gris-Oliver,Olga Rodríguez,Judit Grueso,Pilar Antón,Marta Guzmán,Claudia Aura,Paolo Nuciforo,Katti Jessen,Guillem Argilés,Rodrigo Dienstmann,Andrea Bertotti,Livio Trusolino,Judit Matito,Ana Vivancos,Irene Chicote,Héctor G. Pálmer,Josep Tabernero,Maurizio Scaltriti,José Baselga,Violeta Serra

openalex（2023）

引用0浏览0引用

Figure S2 from MEK Plus PI3K/mTORC1/2 Therapeutic Efficacy is Impacted by tp53 Mutation in Preclinical Models of Colorectal Cancer

Celina García-García,Martín A. Rivas,Yasir H. Ibrahim,María Teresa Calvo,Albert Gris-Oliver,Olga Rodríguez,Judit Grueso,Pilar Antón,Marta Guzmán,Claudia Aura,Paolo Nuciforo,Katti Jessen,Guillem Argilés,Rodrigo Dienstmann,Andrea Bertotti,Livio Trusolino,Judit Matito,Ana Vivancos,Irene Chicote,Héctor G. Pálmer,Josep Tabernero,Maurizio Scaltriti,José Baselga,Violeta Serra

openalex（2023）

引用0浏览0引用

Figure S5 from Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

crossref（2023）

引用0浏览0引用

Table S2 from Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

crossref（2023）

引用0浏览0引用

加载更多

作者统计

#Papers: 36

#Citation: 933

H-Index: 10

G-Index: 17

Sociability: 6

Diversity: 2

Activity: 23

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn